---
figid: PMC10814950__cancers-16-00370-g006
pmcid: PMC10814950
image_filename: PMC10814950__cancers-16-00370-g006.jpg
figure_link: /pmc/articles/PMC10814950/figure/F6/
number: Figure 6
figure_title: Expression of key cell cycle regulators and components of the PI3K signalling
  pathway in response to treatment against UW-CSCC1 (left) and UW-CSCC2 (right).
caption: 'Expression of key cell cycle regulators and components of the PI3K signalling
  pathway in response to treatment against UW-CSCC1 (left) and UW-CSCC2 (right). PIK-75
  (both cell lines: 62.5 nM); dinaciclib (UW-CSCC1: 16 nM; UW-CSCC2: 8 nM). The uncropped
  bolts are shown in Supplementary Materials'
article_title: 'PIK Your Poison: The Effects of Combining PI3K and CDK Inhibitors
  against Metastatic Cutaneous Squamous Cell Carcinoma In Vitro'
citation: Jay R. Perry, et al. Cancers (Basel). 2024 Jan;16(2).
year: '2024'
pub_date: 2024-1-
epub_date: 2024-1-15
doi: 10.3390/cancers16020370
journal_title: Cancers
journa_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords:
- cutaneous squamous cell carcinoma
- cSCC
- metastasis
- targeted therapy
- combination therapy
- phosphoinositid-3-kinase
- PI3K
- PIK-75
- cyclin-dependent kinase
- CDK1/2/5/9
- dinaciclib
---
